First Tracks Bio Clinical Research Study
Still struggling to swallow despite avoiding dense foods?
If you have a confirmed Eosinophilic Oesophagitis (EoE) diagnosis and are between 18-70 years old, you may be eligible to take part in a new clinical research study.
A new Phase 1b clinical research study evaluating an investigational study drug for adults with EoE is now enrolling in Australia.
The study is designed to learn more about the safety and potential effects of this investigational therapy.
If the study is suitable for you and you choose to participate, you will receive study-related care from experienced clinical research professionals at no cost.
By taking part, participants may help advance research that could inform future care for people living with EoE.
You may be eligible if you
- Are 18 to 70 years old - Have a confirmed diagnosis of EoE Other eligibility criteria will apply.
About the study
- The study lasts about 38 weeks, including up to 6 weeks for screening- Participants may receive up to 6 doses of the study drug or placebo - Participants will receive ongoing health assessments and upper endoscopies with biopsies- Participants will answer questions related to symptoms and quality of life
Australian study locations
Taking part in a clinical trial is a personal decision. To learn more about this study, please contact the study location by email.
MelbourneSt Vincent’s Hospital Melbourne - rosemary.sloane@svha.org.auEastern Health - emma.dimitri@monash.edu and sasha.trantino@monash.edu
WoolloongabbaPrincess Alexandra Hospital - teressa.hansen@health.qld.gov.au
WoolloongabbaPrincess Alexandra Hospital - teressa.hansen@health.qld.gov.au
Eupraxia Pharmaceuticals Clinical Study
Having trouble swallowing or drinking?
Eosinophilic oesophagitis (EoE) can make swallowing food or drinks difficult and uncomfortable, sometimes causing food to feel stuck while eating.
This condition can interfere with everyday activities like meals, social situations, and daily routines.
Eupraxia Pharmaceuticals is conducting a clinical research study to evaluate an investigational treatment for adults with active EoE.
Participation criteria:- Adults 18 to 75 years old- Diagnosed with eosinophilic oesophagitis (EoE)- Currently experiencing active EoE symptoms Why participate?- Access to an investigational treatment being studied for EoE- Study visits conducted by experienced research clinicians- No cost to participate- Opportunity to contribute to research focused on improving EoE care
This condition can interfere with everyday activities like meals, social situations, and daily routines.
Eupraxia Pharmaceuticals is conducting a clinical research study to evaluate an investigational treatment for adults with active EoE.
Participation criteria:- Adults 18 to 75 years old- Diagnosed with eosinophilic oesophagitis (EoE)- Currently experiencing active EoE symptoms Why participate?- Access to an investigational treatment being studied for EoE- Study visits conducted by experienced research clinicians- No cost to participate- Opportunity to contribute to research focused on improving EoE care
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (RESOLVE). ClinicalTrials.gov ID: NCT05608681
This clinical trial is being run at several sites in Australia and New Zealand. To learn more about this study, please contact the study location by email.
QueenslandDr Holtmann - Princess Alexandra Hospital, Brisbane - Teressa.Hansen@health.qld.gov.auDr Seltenreich - Coastal Digestive Health, Sunshine Coast - KateSara@cdhresearch.com.au
New South WalesDr Ho - Sydney Clinical Trials, Sydney - admin@sydneyclinicaltrials.com.au
VictoriaDr Burgell - The Alfred, Melbourne - jean.zhang@alfred.org.auDr Garg - Northern Hospital, Melbourne - Ashleigh.Smallman@nh.org.auDr Hannah - Royal Melbourne Hospital, Melbourne - nicola.dalgleish2@mh.org.auDr Nandurkar - Box Hill Hospital (Eastern Health), Melbourne - emma.dimitri@monash.edu
South AustraliaDr Nguyen - Royal Adelaide Hospital, Adelaide - Joshua.Zobel@sa.gov.au Dr Philpott – Lyell McEwin Hospital, Adelaide - Rity.Wong@sa.gov.au Perth Dr Lim – St John of God Midland Public Hospital, Perth - MI.clinicaltrials@sjog.org.au
New ZealandDr Inns - Capital, Coast and Hutt Valley, Wellington - ana.enriquez@ccdhb.org.nzDr Lim - Aotearoa Clinical Trials, Auckland - ethan.chiddicks@aotearoatrials.nzDr Weilert - Waikato Gastroenterology Clinical Trials, Waikato - Heather.logan@waikatodhb.health.nz
New South WalesDr Ho - Sydney Clinical Trials, Sydney - admin@sydneyclinicaltrials.com.au
VictoriaDr Burgell - The Alfred, Melbourne - jean.zhang@alfred.org.auDr Garg - Northern Hospital, Melbourne - Ashleigh.Smallman@nh.org.auDr Hannah - Royal Melbourne Hospital, Melbourne - nicola.dalgleish2@mh.org.auDr Nandurkar - Box Hill Hospital (Eastern Health), Melbourne - emma.dimitri@monash.edu
South AustraliaDr Nguyen - Royal Adelaide Hospital, Adelaide - Joshua.Zobel@sa.gov.au Dr Philpott – Lyell McEwin Hospital, Adelaide - Rity.Wong@sa.gov.au Perth Dr Lim – St John of God Midland Public Hospital, Perth - MI.clinicaltrials@sjog.org.au
New ZealandDr Inns - Capital, Coast and Hutt Valley, Wellington - ana.enriquez@ccdhb.org.nzDr Lim - Aotearoa Clinical Trials, Auckland - ethan.chiddicks@aotearoatrials.nzDr Weilert - Waikato Gastroenterology Clinical Trials, Waikato - Heather.logan@waikatodhb.health.nz